Skip to main content
. 2012 Oct;64(4):939–971. doi: 10.1124/pr.112.006163

Fig. 8.

Fig. 8.

Spinal activators TRPV1. The endogenous agonists of spinal TRPV1 remain unclear; however, a number of possible substances have been suggested, including anandamide, metabolites of lipoxygenases, ω-3 polyunsaturated fatty acids, N-arachidonoyldopamine (NADA), and N-oleoyldopamine (OLDA).